The presence of a homozygous deletion of CDKN2A in an IDH-mutated and 1p/19q co-deleted oligodendroglioma was not considered for grading these tumors, despite the very poor prognosis associated with this alteration in the French POLA cohort POLA (14). This evidence concerns the gene IDH1 and oligodendroglioma.